Open Access

Heart failure in context.

Topic: Chronic Heart Failure
Organised by CHANGE IME supported by an unrestricted educational grant from AstraZeneca

Congress Session

About the speaker

Professor Cecilia Linde

Karolinska Institutet, Stockholm (Sweden)
44 presentations
1 follower

2 more presentations in this session

SGLT2 Inhibitors as a Central Cardio-Renal-Metabolic Therapy: The Modern Day ACE Inhibitor.

Speaker: Doctor M. Vaduganathan (Boston, US)

Thumbnail

Treating the whole spectrum of heart failure.

Speaker: Professor G. Rosano (London, GB)

Thumbnail

Access the full session

SGLT2 inhibitors and heart failure in the cardiorenal spectrum

Speakers: Professor C. Linde, Doctor M. Vaduganathan, Professor G. Rosano
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ACVC Premium Access

Proposed treatment after TTM2.

18 March 2022

ACVC Premium Access

TTM2: a game changer?

18 March 2022

ACVC Premium Access

Clinical trial evidence.

18 March 2022

This platform is supported by

logo Novo Nordisk